Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2020 09:00 ET | Source: AIMM Therapeutics

AIMM Therapeutics Presents Preclinical Data on its Four Oncology Therapies at AACR’s Annual Meeting Session on Antibody Technologies

--World-Class Monoclonal Antibody Technology Advances Beyond Infectious Disease to Focus on Oncology Therapeutics Derived from Cancer Survivors-- --Lead Asset AT1412 On Track Towards CTA Filing in...